The methods of diagnosing and treating localised prostate cancer has changed significantly in the last two decades.

A GRANDAD has vowed to make one “last” trip to cheer on Scotland at the World Cup — three years after he was brought back from the dead. Danny Letford, 73, needed emergency CPR and three sets of ...

Dr. Raza Bokhari, Exec Chairman & CEO, Interviewed by Bloomberg Open Interest Anchor Matt Miller PHILADELPHIA, PA / ACCESS Newswire / February 12, 2026 / Medicus Pharma Ltd. (NASDAQ:MDCX) (“Medicus” ...

AngioDynamics, Inc. announced expanded European indications for its NanoKnife system with irreversible electroporation (IRE) ...

AngioDynamics, Inc. , a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving ...

Imperial College London investigators compared focal therapy with prostate removal surgery for men with prostate cancer that ...

Extracorporeal shock wave therapy (ESWT), a non-invasive modality, shows early promise for type IIIB chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).

Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative positron emission tomography (PET) radiopharmaceuticals, today announced that ...

A trial evaluated the short-term oncologic efficacy of cooled focal therapy ablation using the ProFocal device in men with localized, intermediate-risk prostate cancer.

OncoRes Medical has initiated a clinical trial involving six hospitals in Western Australia and Victoria.

Profound management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the period. Fourth Quarter and Full Year 2025 Results Conference ...

A novel, cooled laser focal therapy (cLFT) exhibits high treatment success for localized prostate cancer (PCa), according to a study published online Jan. 28 in ...